Fiscal Year Ending March 2026 Financial Summary [Japanese Standards] (Consolidated)

Performance Overview

The consolidated performance for the fiscal year ending March 2026 recorded net sales of ¥3.0745 trillion, an increase of 1.2% YoY, and operating profit of ¥231.2 billion, a rise of 9.1%. Ordinary income increased by 19.1% to ¥230.4 billion, with net income attributable to owners of the parent reaching ¥158.8 billion, up 17.6%. The revenue decline in the Essential Chemicals segment was offset by profit growth in the pharmaceutical business and steady performance in the housing segment, resulting in overall revenue and profit growth.

Segment Performance

Healthcare segment achieved net sales of ¥664.1 billion and operating profit of ¥83.5 billion, both up. Housing segment posted net sales of ¥1.077 trillion and operating profit of ¥99.8 billion, both up. Material segment experienced a decline with net sales of ¥1.3062 trillion and operating profit of ¥68.3 billion. Other segments recorded net sales of ¥26.7 billion and operating profit of ¥3.9 billion, both up.

Financial Position and Cash Flows

Total assets increased to ¥4.1379 trillion from the previous year, and net assets increased to ¥2.1656 trillion, raising the equity ratio to 50.5%. Cash flows from operating activities generated ¥303.1 billion, investing activities consumed ¥106.9 billion, and financing activities used ¥245.4 billion. Cash and cash equivalents at the end of the period amounted to ¥372.1 billion.

Dividend Situation

The total annual dividend for the fiscal year ending March 2026 was ¥42 (end of term ¥22), an increase of ¥4 from the previous year. The dividend payout ratio was 35.9%, and the dividend yield on net assets was 2.9%. For the fiscal year ending March 2027, an annual dividend of ¥44 is forecasted.

Earnings Forecast for Fiscal Year Ending March 2027

Net sales are expected to reach ¥3.254 trillion (up 5.8% YoY), operating profit ¥248 billion (up 7.3%), ordinary income ¥247.5 billion (up 7.4%), and net income attributable to owners of the parent ¥160 billion (up 0.8%). Segment-wise, healthcare and housing are expected to increase both revenue and profit, while the material segment is projected to see revenue decline but profit increase.